This content is from: Features

Pharma repurposing: Old drugs, new tricks

The development of new uses for existing drugs raises complex questions about patent law, regulation, economics and health policy. James Nurton reports from a recent conference hosted by UCL and Georgetown Law School

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial

Related